/ODYY

ODYY Stock - Odyssey Health, Inc.

Q: What is the analyst price target for ODYY?

Analyst price target information is not currently available for ODYY.

Q: What is ODYY's market cap?

Market capitalization information is not currently available for ODYY.

Healthcare|Medical - Devices|OTC

$0.03+10.00%

+$0.00 (+10.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.04

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ODYY

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

FY2025

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-1.30

52W High$0.13

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	$-3,416	$-2,374	$-5,552
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-1,020,753	$14.26M	$-5,314,015	$-8,106,580	$-15,860,712
Net Income	$-1,742,691	$-905,771	$-5,919,421	$-8,781,682	$-17,955,478
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.02	$-0.01	$-0.07	$-0.10	$-0.19

Company Overview

Odyssey Health, Inc., a medical company, focuses on developing medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and PRV-001 and PRV-002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was founded in 2014 and is based in Las Vegas, Nevada.

Visit Website

Earnings History & Surprises

ODYY

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.01

Q4 2023

EPS Surprise History

Q1 23

No data

Q2 23

No data

Q4 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2023	Oct 31, 2023	—	$-0.01	—	—
Q2 2023	Apr 30, 2023	—	$-0.02	—	—
Q1 2023	Jan 31, 2023	—	$-0.02	—	—

Frequently Asked Questions about ODYY

What is ODYY's current stock price?

Odyssey Health, Inc. (ODYY) is currently trading at $0.03 per share. The stock has moved +10.00% today.

What is the analyst price target for ODYY?

No analyst price targets are currently available for this stock.

What sector is Odyssey Health, Inc. in?

Odyssey Health, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.

What is ODYY's market cap?

Odyssey Health, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does ODYY pay dividends?

No, Odyssey Health, Inc. does not currently pay a dividend to shareholders.